Aspire Biopharma Inc.

NASDAQ: ASBP · Real-Time Price · USD
0.55
0.01 (2.38%)
At close: Aug 22, 2025, 3:59 PM
0.51
-6.59%
After-hours: Aug 22, 2025, 07:57 PM EDT

Aspire Biopharma Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Net Income
-15.94M -8.93M -243.63K -96.92K -163.87K -76.78K -65.53K -90.27K
Depreciation & Amortization
n/a n/a n/a n/a n/a n/a n/a n/a
Stock-Based Compensation
14.13M n/a n/a n/a n/a n/a n/a n/a
Other Working Capital
-420.18K 1.22M -290.17K 64.02K 64.02K 418.09K -236.77K 109.79K
Other Non-Cash Items
384.85K 8.19M n/a -23.34K -93.11K n/a n/a 4.5K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-326.3K 1.22M -290.17K 64.02K 64.02K 418.09K -236.77K 109.79K
Operating Cash Flow
-1.75M 479.57K -533.8K -56.24K -192.97K 341.3K -302.3K 24.02K
Capital Expenditures
n/a -4 -18.82K 4.00 n/a -18.82K n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a 57.08K -19.13K -19.13K -57.08K 57.08K -19.13K
Investing Cash Flow
n/a n/a 38.26K -19.13K -19.13K -75.9K 38.26K -19.13K
Debt Repayment
2.83M -1.12M 492.48K 2.59M n/a n/a n/a n/a
Common Stock Repurchased
n/a -257.64K n/a -13.78M n/a n/a -284.92M n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 880.66K n/a 11.22M 229.08K -268.82K 285.18M n/a
Financial Cash Flow
3.09M -492.48K 492.48K 28.56K 229.08K -268.82K 268.82K n/a
Net Cash Flow
1.34M -12.91K -3.06K -47.29K 36.11K -3.42K 4.78K n/a
Free Cash Flow
-1.75M 479.57K -533.8K -105.48K -105.48K 265.4K -124.92K 24.02K